Patent ID: 8236759

Claim:
A pharmaceutical composition comprising an analog of glucagon-like peptide-1 according to the formula: [Aib 8,35 ]hGLP-1(7-36)NH 2 ; together with zinc and a pharmaceutically acceptable carrier or diluent, wherein said diluent comprises a pharmaceutically acceptable aqueous solution and said pharmaceutical composition is a clear solution when said composition is administered, said analog of glucagon-like peptide-1 is released within said subject for at least approximately two weeks, with the proviso that said composition does not consist of a clear aqueous ZnCl 2 solution having pH 4 in which said [Aib 8,35 ]hGLP-1(7-36)NH 2 is present at a concentration of 4 mg/ml and said ZnCl 2 is present at a concentration of 0.5 mg/ml.